Coexpression of α2A‐adrenergic and δ‐opioid receptors in substance P‐containing terminals in rat dorsal horn
- 30 January 2009
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 513 (4) , 385-398
Abstract
Agonists acting at α2‐adrenergic and opioid receptors (α2ARs and ORs, respectively) inhibit pain transmission in the spinal cord. When coadministered, agonists activating these receptors interact in a synergistic manner. Although the existence of α2AR/OR synergy has been well characterized, its mechanism remains poorly understood. The formation of heterooligomers has been proposed as a molecular basis for interactions between neuronal G‐protein‐coupled receptors. The relevance of heterooligomer formation to spinal analgesic synergy requires demonstration of the expression of both receptors within the same neuron as well as the localization of both receptors in the same neuronal compartment. We used immunohistochemistry to investigate the spatial relationship between α2ARs and ORs in the rat spinal cord to determine whether coexpression could be demonstrated between these receptors. We observed extensive colocalization between α2A‐adrenergic and δ‐opioid receptors (DOP) on substance P (SP)‐immunoreactive (‐ir) varicosities in the superficial dorsal horn of the spinal cord and in peripheral nerve terminals in the skin. α2AAR‐ and DOP‐ir elements were colocalized in subcellular structures of 0.5 μm or less in diameter in isolated nerve terminals. Furthermore, coincubation of isolated synaptosomes with α2AR and DOP agonists resulted in a greater‐than‐additive increase in the inhibition of K+‐stimulated neuropeptide release. These findings suggest that coexpression of the synergistic receptor pair α2AAR‐DOP on primary afferent nociceptive fibers may represent an anatomical substrate for analgesic synergy, perhaps as a result of protein–protein interactions such as heterooligomerization. J. Comp. Neurol. 513:385–398, 2009.Keywords
This publication has 80 references indexed in Scilit:
- Interaction with Vesicle Luminal Protachykinin Regulates Surface Expression of δ-Opioid Receptors and Opioid AnalgesiaCell, 2005
- Morphine-Induced Changes in δ Opioid Receptor Trafficking Are Linked to Somatosensory Processing in the Rat Spinal CordJournal of Neuroscience, 2004
- Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C-like and MOR-1-like immunoreactivity: Evidence for region-specific processingJournal of Comparative Neurology, 2000
- Gene targeting — homing in on α2-adrenoceptor-subtype functionTrends in Pharmacological Sciences, 1997
- Immunofluorescence analysis of antisense oligodeoxynucleotide-mediated ‘knock-down’ of the mouse δ opioid receptor in vitro and in vivoNeuroscience Letters, 1996
- Co-localization of μ-opioid receptor-like and substance P-like immunoreactivities in axon terminals within the superficial layers of the medullary and spinal dorsal horns of the ratNeuroscience Letters, 1995
- Spinal antinociceptive synergy between clonidine and morphine, U69593, and DPDPE: Isobolographic analysisLife Sciences, 1990
- Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal hornBrain Research, 1985
- Characterization of an immunofluorescence technique for the demonstration of coexisting neurotransmitters within nerve fibers and terminals.Journal of Histochemistry & Cytochemistry, 1985
- Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivoNature, 1980